Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
2/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 9 Months

13 Years 4 Months

Fund AUM

₹6801 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.04%

0.93%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

43

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.21%)
  2. Cipla Ltd(9.4%)
  3. Mankind Pharma Ltd(7.64%)
  4. Dr Reddy's Laboratories Ltd(6.52%)
  5. Biocon Ltd(6.2%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(98.81%)
  2. Basic Materials(1.19%)

Health

(100%)

Equity %

97.98%

99.7%

Debt %

-

-

P/E

32.15

35.73

P/B

3.94

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-1.66%

-1.69%

3-Month Return

-6.54%

-2.35%

6-Month Return

-9.11%

-4.69%

1-Year Return

3.3%

3.56%

3-Year Return

28.11%

24.22%

5-Year Return

18.42%

16.64%

Sharpe

1.3

1.17

Alpha

2.27

0.22

Beta

0.94

0.9

Standard Deviation

15.86

15.21

Information Ratio

0.44

-0.47

Description

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dharmesh Kakkad, Sharmila D’mello

Sailesh Raj Bhan, Kinjal Desai, Divya Sharma, Lokesh Maru

Most Popular Comparisons